GRI Bio to Present at Alliance Global Partner's 2024 Healthcare Company Showcase

Live webcast fireside chat on Tuesday, May 21st at 2:40 PM ETLA JOLLA, CA, May 14, 2024 — GRI Bio, Inc. (NASDAQ: GRI) ("GRI Bio" or the "Company"), a biotechnology company advancing an innovative p

GRI BIOMay 14 12:00

GRI Bio Shares Informational Disclosure Under Regulation FD

TipRanksMay 13 20:12

GRI Bio: Runway To Fund Operating Expenses, Capital Spending Needs Into 3Q >GRI

GRI Bio: Runway To Fund Operating Expenses, Capital Spending Needs Into 3Q >GRI

Dow JonesMay 13 20:04

GRI Bio Q1 EPS $(0.46) Up From $(37.31) YoY

GRI Bio (NASDAQ:GRI) reported quarterly losses of $(0.46) per share. This is a 98.77 percent increase over losses of $(37.31) per share from the same period last year.

BenzingaMay 13 20:03

GRI Bio 1Q Loss $1.9M >GRI

GRI Bio 1Q Loss $1.9M >GRI

Dow JonesMay 13 20:03

GRI Bio Reports First Quarter 2024 Financial Results and Provides Corporate Update

Interim data readout of Phase 2a biomarker study evaluating lead program GRI-0621 for the treatment of Idiopathic Pulmonary Fibrosis (IPF) expected Q3 2024 and topline data on track for Q4 2024 Ongoin

GRI BIOMay 13 12:00